Masakazu Nakashima

Japanese Red Cross Society Wakayama Medical Center

Papers

2

Total Citations

5

H-Index

2

About

Masakazu Nakashima is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes in prostate and bladder cancer care, with a particular focus on robot-assisted techniques. His most significant contribution is a large-scale, real-world analysis of over 8,000 patients who underwent robot-assisted radical prostatectomy (RARP), in which he reevaluated the therapeutic role of extended pelvic lymph node dissection (ext-LDN). This study, published in 2025, provides critical evidence for refining surgical strategies in the modern robotic era, directly impacting clinical decision-making for high-risk prostate cancer patients. Nakashima has also contributed to the understanding of rare urologic tumors, as demonstrated by his case report on bladder paraganglioma—a tumor accounting for less than 0.05% of bladder cancers. In this work, he highlighted the diagnostic challenges and life-threatening risks (acute respiratory distress syndrome) associated with atypical presentations and transurethral resection. While his citation counts are early-stage, his work addresses high-stakes, real-world surgical dilemmas. Nakashima’s research bridges the gap between emerging robotic technology and traditional oncologic principles, offering actionable insights for urologists navigating complex pelvic surgeries and rare tumor management.

Research Focus

Key Achievements

2
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Reevaluating the therapeutic role of extended lymph node dissection in the era of robot-assisted radical prostatectomy
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Japanese Red Cross Society Wakayama Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago